NCT06186167 2024-02-20
Amyloidosis Incidence in High-Risk Cardiac Device Patients
Midwest Heart & Vascular Specialists
Unknown
Clinical Trials
9 trialsNCT05174338 2023-09-06
CARS
Cedars-Sinai Medical Center
Unknown
NCT05951816 2023-07-19
A Phase 1 Study of 99mTc-p5+14 in Healthy Volunteers and Patients With AL or ATTR Systemic Amyloidosis
University of Tennessee Graduate School of Medicine
Phase 1 Unknown
NCT04006223 2023-02-14
The Diagnostic Value of Hybrid PET/MR for Systemic Amyloidosis
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Unknown
NCT03252600 2023-01-25
Lenalidomide, Dexamethasone, and Elotuzumab With or Without Cyclophosphamide in Treating Patients With Relapsed Primary Amyloidosis
Barbara Ann Karmanos Cancer Institute
Phase 2 Unknown
NCT04474938 2022-05-10
Daratumumab Combined With Bortezomib and Dexamethasone in Mayo 04 Stage III Light Chain Amyloidosis
Peking Union Medical College Hospital
Phase 2 Unknown
NCT05277493 2022-04-27
A Registry of Chinese AL Amyloidosis Patients Treated With Subcutaneous or Intravenous Daratumumab
Peking Union Medical College Hospital
Unknown
NCT05150353 2021-12-09
AMYLOCARP
Ramsay Générale de Santé
Phase NA Unknown
NCT04612582 2020-11-03
Comparison of BTD and BCD Based Regimens in the Treatment of AL Amyloidosis
Guangdong Provincial People's Hospital
Phase 4 Unknown